Sign in / Join Now
ETFs & Funds
!¡!¡ Up 74% on news of clinical trial updates!!!! Keep it moving +++>
Add a reply...
Latest StockTalks »
people get RPRX breaking news and analysis by email alert.
Get email alerts on RPRX »
Repros Therapeutics Inc.
Get latest price
From other sites
Repros Announces Acceptance Of Dossier For Enclomiphene For Secondary Hypogonadism By European Authorities
at TheStreet (Oct 5, 2016)
FDA Schedules Advisory Committee Meeting To Discuss Secondary Hypogonadism
at TheStreet (Sep 26, 2016)
Repros Announces Submission Of MAA To The European Medicines Agency For Enclomiphene In The Treatment Of Secondary Hypogonadism
at TheStreet (Sep 12, 2016)
Repros Therapeutics' (RPRX) Proellex Positive in Phase II
at Zacks.com (Sep 8, 2016)
Repros Provides Phase 2 Results Showing Positive Outcomes For Oral Proellex® In Women With Moderate To Severe Endometriosis
at TheStreet (Sep 7, 2016)